|
2018 |
Continuous remote ischemic conditioning attenuates cognitive and motor deficits from moderate traumatic brain injury. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2018 |
Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications. |
John M. Streicher, PhD |
|
2018 |
A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain. |
Tally Largent-Milnes, PhD, John M. Streicher, PhD, Todd Vanderah, PhD |
|
2019 |
Cellular Specificity and Inter-cellular Coordination in the Brain Bioenergetic System: Implications for Aging and Neurodegeneration. |
Fei Yin, Ph.D. |
|
2019 |
Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2019 |
The Role of Heat Shock Proteins in Regulating Receptor Signal Transduction. |
John M. Streicher, PhD |
|
2019 |
Maternity Leave in Residency: A Multicenter Study of Determinants and Wellness Outcomes. |
Sigrid Gardner Williams |
|
2019 |
Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2019 |
Neuroendocrine aging precedes perimenopause and is regulated by DNA methylation. |
Fei Yin, Ph.D. |
|
2019 |
Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids. |
John M. Streicher, PhD |
|
2019 |
Buchwald Hartwig diversification of unprotected halotryptophans, halotryptophan containing tripeptides and the natural product barettin in aqueous conditions. |
Christopher Cartmell |
|
2019 |
Buchwald Hartwig diversification of unprotected halotryptophans, halotryptophan containing tripeptides and the natural product barettin in aqueous conditions |
Christopher Cartmell |
|
2019 |
Animal Models for the Study of Bone-Derived Pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2019 |
A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction. |
Tally Largent-Milnes, PhD, Kathleen Rodgers, Ph.D., Todd Vanderah, PhD |
|
2019 |
The Alpha Isoform of Heat Shock Protein 90 and the Co-chaperones p23 and Cdc37 Promote Opioid Anti-nociception in the Brain. |
John M. Streicher, PhD |
|
2019 |
Migraine, A Review of Basic, Clinical, Translational Approaches to New Treatment |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2019 |
Development and Characterization of An Injury-free Model of Functional Pain in Rats by Exposure to Red Light. |
Mohab M. Ibrahim, PhD, MD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2020 |
Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders. |
Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2020 |
Potential therapeutic treatments of cancer-induced bone pain. |
Todd Vanderah, PhD |
|
2020 |
Haploinsufficiency of tau decreases survival of the mouse model of Niemann-Pick disease type C1 but does not alter tau phosphorylation. |
Todd Vanderah, PhD |
|
2020 |
The endomorphin-1/2 and dynorphin-B peptides display biased agonism at the mu opioid receptor. |
John M. Streicher, PhD |
|
2020 |
Editorial: Novel Molecular Targets for the Treatment of Pain. |
John M. Streicher, PhD |
|
2020 |
Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity. |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2020 |
Glial neuroimmune signaling in opioid reward. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2020 |
Activation of sphingosine-1-phosphate receptor subtype 1 in the central nervous system contributes to morphine-induced hyperalgesia and antinociceptive tolerance in rodents. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
